Display options
Share it on

J Biomed Res. 2013 Nov;27(6):460-6. doi: 10.7555/JBR.27.20130137. Epub 2013 Sep 25.

I -123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients.

Journal of biomedical research

Weihua Zhou, Ji Chen

Affiliations

  1. Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA.

PMID: 24285944 PMCID: PMC3841471 DOI: 10.7555/JBR.27.20130137

Abstract

Compared to antiarrhythmic drugs, implantable cardioverter defibrillator (ICD) leads to a more significant improvement in preventing ventricular arrhythmia in heart failure patients. However, an important question has been raised that how to select appropriate patients for ICD therapy. I-123 metaiodobenzylguanidine (MIBG) planar and SPECT imaging have shown great potentials to predict ventricular arrhythmia in heart failure patients by assessing the abnormalities of the sympathetic nervous system. Clinical trials demonstrated that several parameters measured from I-123 MIBG planar and SPECT imaging, such as heart-to-mediastinum ratio, washout rate, defect score, and innervation/perfusion mismatch, predicted ventricular arrhythmias in heart failure patients. This paper introduces the current practice of ICD therapy and reviews the technical background of I-123 MIBG planar and SPECT imaging and their clinical data in predicting ventricular arrhythmia.

Keywords: I-123 metaiodobenzylguanidine (MIBG); heart failure; implantable cardioverter defibrillator; ventricular arrhythmia

References

  1. J Intern Med. 1995 Feb;237(2):135-41 - PubMed
  2. J Am Coll Cardiol. 1993 Nov 1;22(5):1344-53 - PubMed
  3. J Nucl Cardiol. 2011 Feb;18(1):82-9 - PubMed
  4. Circulation. 1990 Aug;82(2 Suppl):I103-13 - PubMed
  5. Circulation. 2009 Mar 3;119(8):1069-71 - PubMed
  6. N Engl J Med. 2005 Jan 20;352(3):225-37 - PubMed
  7. N Engl J Med. 1991 Aug 29;325(9):656-7 - PubMed
  8. J Nucl Med. 2008 Jun;49(6):907-14 - PubMed
  9. Cardiovasc Res. 2001 May;50(2):177-85 - PubMed
  10. Circulation. 2013 Jan 1;127(1):143-52 - PubMed
  11. Lancet. 2005 May 28-Jun 3;365(9474):1877-89 - PubMed
  12. Circulation. 2009 Apr 14;119(14):e391-479 - PubMed
  13. J Nucl Cardiol. 2012 Feb;19(1):92-9 - PubMed
  14. J Nucl Med. 2008 Feb;49(2):225-33 - PubMed
  15. Circulation. 1998 Nov 24;98(21):2334-51 - PubMed
  16. J Nucl Cardiol. 2002 Jan-Feb;9(1):15-22 - PubMed
  17. Ann Nucl Med. 2010 Apr;24(3):125-35 - PubMed
  18. J Am Coll Cardiol. 2010 Jun 15;55(24):2769-77 - PubMed
  19. J Nucl Cardiol. 2003 Mar-Apr;10(2):121-31 - PubMed
  20. J Am Coll Cardiol. 2010 Feb 23;55(8):774-82 - PubMed
  21. JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108 - PubMed
  22. J Nucl Cardiol. 2006 Mar-Apr;13(2):251-60 - PubMed
  23. J Am Coll Cardiol. 2010 May 18;55(20):2212-21 - PubMed
  24. Circulation. 1998 Jan 27;97(3):282-9 - PubMed
  25. J Am Coll Cardiol. 2007 Sep 18;50(12):1158-60 - PubMed
  26. J Nucl Cardiol. 2004 Mar-Apr;11(2):126-33 - PubMed
  27. J Physiol. 2010 Dec 15;588(Pt 24):4855-6 - PubMed
  28. Kaku Igaku. 1997 Dec;34(12):1139-48 - PubMed
  29. Circulation. 1988 Oct;78(4):1008-19 - PubMed
  30. Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):547-53 - PubMed
  31. Circ Cardiovasc Imaging. 2008 Sep;1(2):131-40 - PubMed
  32. J Physiol. 2007 May 1;580(Pt.3):895-906 - PubMed
  33. Heart. 2007 Oct;93(10):1213-8 - PubMed
  34. Eur Heart J. 2008 Oct;29(19):2388-442 - PubMed
  35. Nucl Med Commun. 2010 Jul;31(7):617-28 - PubMed
  36. J Nucl Cardiol. 2012 Feb;19(1):142-52; quiz 153-7 - PubMed

Publication Types